Fig. 3From: Acceptability of neural stem cell therapy for cerebral palsy: survey of the Australian cerebral palsy communitySupport for NSC therapy across patient ages. Participant support of neural stem cell (NSC) therapy given the need to administer them via neurosurgery and in conjunction with immunosuppression across five age groups: a newborns, 0–3 months, b infants, 0–18 months, c children, 18 months and over, d teenagers and e adultsBack to article page